Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I don't think the market was looking for a profit!

I know I didn't expect one . It would have been nice to break even. I believe all eyes are on the ITC and other legal actions. I always said TPL was the weak link. Thats not going to change. Since TPL is a 22.5% owner it is in their best interest to get as much as possible.

GLTA

Share
New Message
Please login to post a reply